The global estrogen receptor agonist market is anticipated to grow at a CAGR of 15.76% over the forecast period (2022 – 2030).
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |